Existing and emerging therapies for the treatment of familial hypercholesterolemia

Familial hypercholesterolemia (FH), an autosomal dominant disorder of LDL metabolism that is characterized by elevated LDL-cholesterol, is commonly encountered in patients with atherosclerotic coronary heart disease. Combinations of cholesterol-lowering therapies are often used to lower LDL-choleste...

Descripción completa

Detalles Bibliográficos
Autor principal: Rosenson, Robert S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Thematic Review Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065289/
https://www.ncbi.nlm.nih.gov/pubmed/33716107
http://dx.doi.org/10.1016/j.jlr.2021.100060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065289/
https://www.ncbi.nlm.nih.gov/pubmed/33716107
http://dx.doi.org/10.1016/j.jlr.2021.100060

Ejemplares similares